Tetrahydrocannabinol (THC), once the darling of the industry, seems now to be playing second fiddle to its counterpart, cannabidiol (CBD). THC-free products are now all the rage in the wellness and pharmaceutical space due to their powerful therapeutic effects without the intoxicating experience.
Cannabidiolic acid (CBDA) is a little-known cannabinoid with major therapeutic potential. In preliminary studies, CBDA has shown to treat inflammation, anxiety, seizures, and even certain types of cancer. CBDA is now seen as the next frontier in cannabinoid-based therapy.